Skip to main content
. 2021 May 14;10(5):1201. doi: 10.3390/cells10051201

Table 3.

A summary of noncanonical interaction partners of FGFR1-4 which have been linked to cancer.

FGFR Partner Cancer Subtype Consequence of Interaction Associated References
FGFR1 Anosmin-1 Brain; Glioblastoma Promotes motility and invasion in FGFR-dependent manner [259]
Collagen type IV Pancreatic Sustained ERK1/2 activation [10,176,177,260]
EGFR Lung Increases AKT and STAT3 signaling [261]
EPHA4 Glioma Potentiates FGFR1-signaling [262]
Galectin-1 Osteosarcoma Activated FGFR1, increased proliferation and survival [263]
Galectin-3 Osteosarcoma FGFR1 plasma membrane clustering [263]
GALNT14 Breast Promotes FGFR activation [264]
Integrin-αVβ3 Breast Increased tumorigensis, angiogenesis and EMT [265,266]
Integrin-β3 Breast Disrupts colocalization with E-cadherin and promotes EMT [267]
L1CAM Glioma Promote motility and proliferation [268,269]
N-cadherin Breast Stabilizes FGFR1 at plasma membrane, promoting sustained ERK1/2 signal, increased invasion, motility and metastasis [270,271]
NRP1 Breast FGFR1-NRP1 complex increases during EMT [272]
RET-KIF5B, EGFR RET-KIF5B fusion positive cancers Increases FGFR activation and promotes inavdopodia formation [273]
TGFBR3 Neuroblastoma Activates ERK1/2 signaling, promoting differentiation, suppressing tumor growth and metastasis [274]
FGFR2 EGFR Breast Induces EGFR T693 phosphorylation, recycling and stabilization and increases cell cycle outputs [275]
EPHA4 Glioma Increases proliferation and migration [262]
RET-KIF5B, EGFR RET-KIF5B fusion positive cancers Increases FGFR activation and promotes inavdopodia formation [273]
FGFR3 PYK2 Multiple myeloma Increases STAT5 activation [276]
TAK1 Multiple myelomaBladder Cell adhesion and NFκB-dependent transcription [277]
FGFR4 NCAM Pancreatic Promote neurite outgrowth [278]
NCAM Pituitary neoplasia When interaction is inhibited increases invasive phenotype [279]

EGFR, epidermal growth factor receptor; EMT, epithelial-mesenchymal transition; EPHA4, ephrin type A receptor 4; ERK1/2, extracellular signal-regulated protein kinase 1/2; FGFR, fibroblast growth factor receptor; L1CAM, L1 cell adhesion molecule; GALNT14, polypeptide N-acetyl galactosaminyltransferase 14; NFκB, nuclear factor κB; NRP1, neuropilin 1; PYK2, focal adhesion nonreceptor protein tyrosine kinase 2; RET-KIF5B, rearranged during transfection (RET)-kinesin family member 5B (KIF5B); STAT3/5; signal transducer and activator of transcription 3/5; TAK1, transforming growth factor α-activated kinase 1; TGFBR3, transforming growth factor receptor β; T693, threonine 693.